Differentiation of embryonic stem cells towards hematopoietic cells: Progress and pitfalls

Current Opinion in Hematology

Volumn 15, Issue 4, 2008, Pages 312-318

  Tian, Xinghui ^a   Kaufman, Dan S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Embryonic stem cells; Genetic modification; Hemangioblast; Hematopoietic cells

Indexed keywords

CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; EMBRYONIC STEM CELL; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; CYTOLOGY; HEMATOPOIETIC STEM CELL;

CELL DIFFERENTIATION; CELL LINEAGE; EMBRYONIC STEM CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS;

EID: 47149117047     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328302f429     Document Type: Review

References (73)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292:154-156.
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78:7634-7638.
3. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 1995; 92:7844-7848.
4. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
5. Kaufman DS, Hanson ET, Lewis RL, et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001; 98:10716-10721.
6. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005; 19:1129-1155.
7. Nishikawa SI, Nishikawa S, Hirashima M, et al. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 1998; 125:1747-1757.
8. Porcher C, Swat W, Rockwell K, et al. The T cell leukemia oncoprotein SCL/ tal-1 is essential for development of all hematopoietic lineages. Cell 1996; 86:47-57.
9. Pevny L, Simon MC, Robertson E, et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991; 349:257-260.
10. Okuda T, van Deursen J, Hiebert SW, et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84:321-330.
11. Wang Q, Stacy T, Binder M, et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996; 93:3444-3449.
12. Robb L, Lyons I, Li R, et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 1995; 92:7075-7079.
13. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking theT-cell leukaemia oncoprotein tal-1/SCL. Nature 1995; 373:432-434.
14. Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev 1994; 8:1184-1197.
15. Galan-Caridad JM, Harel S, ArenzanaTL, et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007; 129:345-357.
16. Choi K, Kennedy M, Kazarov A, et al. A common precursor for hematopoietic and endothelial cells. Development 1998; 125:725-732.
17. Kennedy M, Firpo M, Choi K, et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 1997; 386:488-493.
18. Wang L, Li L, Shojaei F, et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangio-blastic properties. Immunity 2004; 21:31-41.
19. Zambidis ET, Peault B, ParkTS, et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005; 106:860-870.
20. Kennedy M, D'Souza SL, Lynch-Kattman M, et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007; 109:2679-2687.
21. Woll PS, Morris JK, Painschab MS, et al. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008; 111:122-131.
22. Perlingeiro RC. Endoglin is required for hemangioblast and early hematopoietic development. Development 2007; 134:3041-3048.
23. Huber TL, Kouskoff V, Fehling HJ, et al. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 2004; 432:625-630.
24. Fehling HJ, Lacaud G, Kubo A, et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003; 130:421 7-4227.
25. Park C, Afrikanova I, Chung YS, et al. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 2004; 131:2749-2762.
26. Lugus JJ, Chung YS, Mills JC, et al. GATA2 functions at multiple steps in hemangioblast development and differentiation. Development 2007; 134:393-405.
27. Zafonte BT, Liu S, Lynch-Kattman M, et al. Smad1 expands the hemangioblast population within a limited developmental window. Blood 2007; 109:516-523.
28. Zambidis ET, Sinka L, Tavian M, et al. Emergence of human angiohematopoietic cells in normal development and from cultured embryonic stem cells. Ann N Y Acad Sci 2007; 1106:223-232.
29. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105:617-626.
30. Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006; 108:2095-2105.
31. Lu SJ, Li F, Vida L, Honig GR. CD34+CD38- hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood 2004; 103:4134-4141.
32. Lu SJ, Feng Q, Caballero S, et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007; 4:501-509.
33. Srivastava AS, Nedelcu E, Esmaeli-Azad B, et al. Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells. Stem Cells 2007; 25:1456-1461.
34. Tian X, Morris JK, Linehan JL, Kaufman DS. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol 2004; 32:1000-1009.
35. ChadwickK, Wang L, Li L, et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003; 102:906-915.
36. Pick M, Azzola L, Mossman A, et al. Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 2007; 25:2206-2214.
37. Davis RP, Ng ES, Costa M, et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 2008; 111:1876-1884.
38. Zhang P, Li J, Tan Z, et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 2008; 111:1933-1941.
39. Staal FJ, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 2005; 5:21-30.
40. Naito AT, Shiojima I, Akazawa H, et al. Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci USA 2006; 103:19812-19817.
41. Anderson JS, Bandi S, Kaufman DS, Akkina R. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology 2006; 3:24.
42. Gaur M, Kamata T, Wang S, et al. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocy-topoiesis and integrin function. J Thromb Haemost 2006; 4:436-442.
43. Qiu C, Olivier EN, Velho M, Bouhassira EE. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood 2008; 111:2400-2408.
44. Slukvin II, Vodyanik MA, Thomson JA, et al. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J Immunol 2006; 176:2924-2932.
45. Galic Z, Kitchen SG, Kacena A, et al. T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci U S A 2006; 103:11742-11747.
46. Woll PS, Martin CH, Miller JS, Kaufman DS. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 2005; 175:5095-5103.
47. Qiu C, Hanson E, Olivier E, et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005; 33:1450-1458.
48. Olivier EN, Qiu C, Velho M, et al. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol 2006; 34:1635- 1642.
49. Chang KH, Nelson AM, Cao H, et al. Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin. Blood 2006; 108:1515-1523.
50. Woll PS, Marcus R, Kaufman DS. NK cells derived from human embryonic stem cells demonstrate more effective in vivo clearance of xenografted human tumor cells compared to NK cells derived from cord blood. Blood 2007; 110 (Suppl 1):806a.
51. Martin CH, Woll PS, Zúñiga-Pflücker JC, Kaufman, DS. Differences in lymphocyte developmentalpotential between human embryonicstemcell and umbilical cord blood-derived hematopoietic progenitor cells. Blood (in press).
52. Tavian M, Robin C, Coulombel L, Peault B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 2001; 15:487-495.
53. Wang L, Menendez P, Shojaei F, et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 2005; 201:1603-1614.
54. Tian X, Woll PS, Morris JK, et al. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 2006; 24:1370-1380.
55. Narayan AD, Chase JL, Lewis RL, et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2006; 107:2180-2183.
56. Sasaki K, Nagao Y, Kitano Y, et al. Hematopoietic microchimerism in sheep after in utero transplantation of cultured cynomolgus embryonic stem cells. Transplantation 2005; 79:32-37.
57. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002; 109:29-37.
58. Chan KM, Bonde S, Klump H, Zavazava N. Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood 2008; 111:2953-2961.
59. Wang Y, Yates F, Naveiras O, et al. Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci U S A 2005; 102:19081-19086.
60. Lu SJ, Feng Q, Ivanova Y, et al. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev 2007; 16:547-559.
61. Bowles KM, Vallier L, Smith JR, et al. HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells 2006; 24:1359-1369.
62. Papapetrou EP, Zoumbos NC, Athanassiadou A. Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects. Gene Ther 2005; 12 (Suppl 1):S118-S130.
63. Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007; 25:681-686.
64. Wilber A, Linehan JL, Tian X, et al. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 2007; 25:2919-2927.
65. Zaehres H, Lensch MW, Daheron L, et al. High-efficiency RNA interference in human embryonic stem cells. Stem Cells 2005; 23:299-305.
66. Irion S, Luche H, Gadue P, et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 2007; 25:1477-1482.
67. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-1920.
68. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451:141-146.
69. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. References [671-69] are stunning studies showing that pluripotent stem cells can be generated from reprogrammed human somatic cells by using defined transcriptional factors. Although the genes used for reprogramming vary slightly between the groups, the overall result demonstrates these effects to create induced pluripotent stem (iPS) cells are very reproducible between groups. Additionally, reference [68] demonstrates development of hematopoietic cells from human iPS cells.
70. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
71. Okita K, IchisakaT, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448:313-317.
72. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448:318-324. References [71] and [72] demonstrate the remarkable ability of mouse iPS cells to form germline chimeras. These studies definitively demonstrate that iPS cells are pluripotent and may offer important alternatives to use of mouse embryonic stem cells for genetic and developmental studies.
73. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318:1920-1923.